Angion Biomedica Corp.

NASDAQ: ANGN · Real-Time Price · USD
1.00
0.00 (0.00%)
At close: Jun 01, 2023, 10:00 PM

Angion Biomedica Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 2.3M 28.31M
Cost of Revenue
n/a n/a 433K
Gross Profit
n/a 2.3M 27.88M
Operating Income
-44.99M -30.44M -39.31M
Interest Income
777K n/a n/a
Pretax Income
-51.9M -38.81M -54.57M
Net Income
-51.9M -55.7M -53.77M
Selling & General & Admin
11.33M 14.64M 18.49M
Research & Development
33.66M 18.1M 48.7M
Other Expenses
n/a n/a n/a
Operating Expenses
44.99M 32.74M 67.19M
Interest Expense
-455K 805K n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
n/a 32.74M 67.62M
Income Tax Expense
n/a 16.89M -801K
Shares Outstanding (Basic)
12.2M 30.04M 28.24M
Shares Outstanding (Diluted)
12.2M 30.04M 28.24M
EPS (Basic)
-4.25 -1.85 -1.9
EPS (Diluted)
-4.25 -1.85 -1.9
EBITDA
-44.99M -20.12M -39.31M
EBIT
n/a -28.82M -56.42M
Depreciation & Amortization
n/a 10.32M 801K